BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bansal KK, Mishra DK, Rosling A, Rosenholm JM. Therapeutic Potential of Polymer-Coated Mesoporous Silica Nanoparticles. Applied Sciences 2020;10:289. [DOI: 10.3390/app10010289] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Mehta S, Suresh A, Nayak Y, Narayan R, Nayak UY. Hybrid nanostructures: Versatile systems for biomedical applications. Coordination Chemistry Reviews 2022;460:214482. [DOI: 10.1016/j.ccr.2022.214482] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
2 Sreeharsha N, Philip M, Krishna SS, Viswanad V, Sahu RK, Shiroorkar PN, Aasif AH, Fattepur S, Asdaq SMB, Nair AB, Attimarad M, Venugopala KN. Multifunctional Mesoporous Silica Nanoparticles for Oral Drug Delivery. Coatings 2022;12:358. [DOI: 10.3390/coatings12030358] [Reference Citation Analysis]
3 Busa P, Koutavarapu R, Kuthati Y. Polydopamine-Coated Copper-Substituted Mesoporous Silica Nanoparticles for Dual Cancer Therapy. Coatings 2022;12:60. [DOI: 10.3390/coatings12010060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cao D, Zuo H, Jiang M, Huang Y, Li L, Lin F, Liu Y. Development of a multi-arm polyrotaxanes modified mesoporous silica-coated gold nanoplatform for protecting endothelial progenitor cells against high glucose environment. J Biomater Appl 2021;:8853282211041210. [PMID: 34463189 DOI: 10.1177/08853282211041210] [Reference Citation Analysis]
5 Managò S, Tramontano C, Delle Cave D, Chianese G, Zito G, De Stefano L, Terracciano M, Lonardo E, De Luca AC, Rea I. SERS Quantification of Galunisertib Delivery in Colorectal Cancer Cells by Plasmonic-Assisted Diatomite Nanoparticles. Small 2021;17:e2101711. [PMID: 34302422 DOI: 10.1002/smll.202101711] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
6 Day CM, Sweetman MJ, Song Y, Plush SE, Garg S. Functionalized Mesoporous Silica Nanoparticles as Delivery Systems for Doxorubicin: Drug Loading and Release. Applied Sciences 2021;11:6121. [DOI: 10.3390/app11136121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Xue X, Gong H, Zheng H, Ye L. Boronic Acid Functionalized Nanosilica for Binding Guest Molecules. ACS Appl Nano Mater 2021;4:2866-75. [PMID: 33842857 DOI: 10.1021/acsanm.1c00005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Saha S, Roy P, Chakraborty J. Mesoporous silica-biopolymer-based systems in drug delivery applications. Tailor-Made and Functionalized Biopolymer Systems 2021. [DOI: 10.1016/b978-0-12-821437-4.00002-5] [Reference Citation Analysis]
9 Qu Z, Wong KY, Moniruzzaman M, Begun J, Santos HA, Hasnain SZ, Kumeria T, Mcguckin MA, Popat A. One‐Pot Synthesis of pH‐Responsive Eudragit‐Mesoporous Silica Nanocomposites Enable Colonic Delivery of Glucocorticoids for the Treatment of Inflammatory Bowel Disease. Adv Therap 2021;4:2000165. [DOI: 10.1002/adtp.202000165] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
10 Dement’eva OV. Mesoporous Silica Container Particles: New Approaches and New Opportunities. Colloid J 2020;82:479-501. [DOI: 10.1134/s1061933x20050038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bhatia R, Sharma A, Narang RK, Rawal RK. Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy. Curr Mol Pharmacol 2021;14:350-66. [PMID: 32744982 DOI: 10.2174/1874467213666200730114943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]